Rwanda - Operational
Active registration portfolio at Rwanda FDA. 31 dossiers submitted, 1 MA received.
ActiveRegulatory Affairs
THESYL provides regulatory affairs services for pharmaceutical manufacturers and Marketing Authorization Holders entering and operating across African markets. We manage product registration, regulatory strategy, dossier compilation, and regulatory intelligence applying ICH-standard methodology within Africa's evolving regulatory landscape.
Request a regulatory assessmentGeographic Scope
Active registration portfolio at Rwanda FDA. 31 dossiers submitted, 1 MA received.
ActiveRequirements mapped across Uganda, Kenya, Tanzania, Burundi, and DRC.
ExpandingContinental Africa and global markets as THESYL's practice grows.
Long-term31
Registration Submissions
Rwanda FDA as of June 2025
3
Product Categories
Generics, Biologics/Biosimilars, Nutraceuticals
6
African Markets
1 active, 5 under regulatory mapping
Our Approach
We prioritize patient safety and healthcare product accessibility in every regulatory decision.
We coordinate closely with authorities, clients, and internal teams to secure approvals efficiently.
Strategies are adapted to each product, market, and regulatory environment.
Scientific, clinical, and market data shape better submissions and ongoing compliance.
Direct understanding of national review processes and authority expectations.
Dossiers meet international quality standards regardless of target market.
Strategy is built on current authority behavior and active regulatory monitoring.
Engagements scale from one market to multi-market programmes with RMS support.
Service 01
THESYL manages registration on behalf of MAHs across African markets including pre-submission planning, dossier gap analysis, authority submission, and post-registration maintenance.
Registration Pathways
01
Comprehensive quality, safety, and efficacy review for complex products.
02
Leverages prior SRA or WHO assessments to shorten timelines.
03
Focused review for generics emphasizing quality and BE evidence.
What we manage
Markets covered
Rwanda
Rwanda FDA
ActiveUganda
NDA Uganda
MappedKenya
PPB/KEBS
MappedTanzania
TMDA
MappedBurundi
ABREMA
MappedDRC
ACOREP
MappedService 02
Clinical trial initiation requires coordinated submissions to competent authorities and ethics committees, often in parallel. THESYL manages both tracks from startup through lifecycle compliance.
Service 03
Requirements are evolving rapidly. THESYL tracks NRA updates, continental harmonisation initiatives, and operational authority practices to inform submission strategy and lifecycle compliance.
Service 04
We produce high-quality regulatory and safety documents aligned to ICH CTD structure and African authority requirements.
Africa's regulatory landscape is converging. We track the harmonisation frameworks already affecting submission strategy and those shaping the next five years.
Continental harmonisation and joint review framework.
Regulatory convergence across AU member states.
Joint assessment framework across member NRAs.
Mutual recognition-driven acceleration pathway.
Whether you need a single-market strategy or a multi-country programme, we assess your product, dossier readiness, and applicable pathways to define clear requirements and realistic timelines.